Drugs for hypertension
Article Abstract:
Most antihypertensive drugs are diuretics, beta blockers, calcium channel blockers, ACE inhibitors or angiotensin receptor antagonists. Studies have shown that diuretics and beta blockers alone can lower mortality rates from hypertension. However, black patients do not respond as well to beta blockers. Diabetics may benefit from ACE inhibitors, as can patients with congestive heart failure. Calcium channel blockers may benefit people with elevated blood lipid levels. Hypertension treatment should be tailored to the individual patient and if one class of drugs is not effective, another class can be chosen.
Publication Name: Medical Letter on Drugs and Therapeutics
Subject: Health
ISSN: 0025-732X
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Fenoldopam -- a new drug for parenteral treatment of severe hypertension
Article Abstract:
The FDA has approved the drug fenoldopam for the treatment of severe hypertension. Sold under the trade name Corlopam, it is given intravenously. In addition to lowering blood pressure, it improves kidney function. It has also been used in patients with congestive heart failure. Side effects include flushing, dizziness, headache and nausea. It is as effective as sodium nitroprusside in lowering blood pressure.
Publication Name: Medical Letter on Drugs and Therapeutics
Subject: Health
ISSN: 0025-732X
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Isradipine for hypertension. Moexipril: another ACE inhibitor for hypertension. Betaxolol for hypertension
- Abstracts: Intravenous immunoglobulin: prevention and treatment of disease. Intravenous immunoglobulin therapy for toxic shock syndrome
- Abstracts: Increased chloride reabsorption as an inherited renal tubular defect in familial type II pseudohypoaldosteronism
- Abstracts: Orthostatic hypotension in human immunodeficiency virus infection may be the result of generalized autonomic nervous system dysfunction. part 2
- Abstracts: Hepatic fibrosis - new therapeutic approaches. Response to interferon alfa-2b in a patient with systemic mastocytosis